Chimeric Antigen Receptor T (CAR-T) Cells Global Market Report 2023

Description

“Chimeric Antigen Receptor T (CAR-T) Cells Global Market Report 2023 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on chimeric antigen receptor t (car-t) cells market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for chimeric antigen receptor t (car-t) cells? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The chimeric antigen receptor t (car-t) cells market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

1) By Target Antigen: CD19; CD22; Other Antigens

2) By Application: Acute Lymphoblastic Leukaemia; Diffuse Large B-Cell Lymphoma; Other Applications

3) By End User: Hospitals; Cancer Research Centres; Clinics

Companies Mentioned: Novartis International AG; Pfizer Inc; Gilead Sciences Inc; Autolus Therapeutics Plc; CARsgen Therapeutics Company Limited

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Major players in the chimeric antigen receptor t (car-t) cells market are: Novartis International AG, Pfizer Inc., Gilead Sciences Inc., Autolus Therapeutics Plc, CARsgen Therapeutics Company Limited, Bristol-Myers Squibb Company, Sorrento Therapeutics Inc., Legend Biotech, Mustang Bio Inc., Bluebird Bio Inc., and Eureka Therapeutics Inc.

The global chimeric antigen receptor T (CAR-T) cells market is expected to grow from $1.96 billion in 2022 to $2.76 billion in 2023 at a compound annual growth rate (CAGR) of 40.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The chimeric antigen receptor T (CAR-T) cells market is expected to grow to $10.24 billion in 2027 at a CAGR of 38.8%.

The chimeric antigen receptor T (CAR-T) cells market includes revenues earned by entities by providing chimeric antigen receptor T (CAR-T) cells that are used to cure blood cancers. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The chimeric antigen receptor T (CAR-T) cells refers to genetically engineered cells that fight with cancer cells to treat the disease. The chimeric antigen receptor T (CAR-T) cells therapy is a form of treatment in which the patient's T cells, a particular type of immune system cell, are altered in a lab so they will target cancer cells. Blood from a patient is drawn to get T cells. Then, in the lab, T cells are given the gene for a unique receptor, chimeric antigen receptor T (CAR-T), that attaches to a particular protein on the patient's cancer cells and helps fight cancer.

North America was the largest region in the chimeric antigen receptor T (CAR-T) cells market in 2022. The regions covered in the chimeric antigen receptor T (CAR-T) cells market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The main target antigens of chimeric antigen receptor T (CAR-T) cells are CD19, CD22, and other antigens. The CD19 antigen refers to use of CAR T-cells for the immunotherapy-based treatment for B-cell acute lymphoblastic leukemia. The application of chimeric antigen receptor T (CAR-T) cells includes acute lymphoblastic leukemia, diffuse large B-cell lymphoma, and other applications that are used in hospitals, cancer research centers, and clinics.

The increasing occurrences of cancer is driving the chimeric antigen receptor T (CAR-T) cells market. Cancer is a chronic disease in which normal body cells divide and grow without any control and affect the nearest body tissue and turn into tumors cells. The chimeric antigen receptor T (CAR-T) cells are used to treat various types of cancers such as hematological malignancies, including acute lymphoblastic leukemia, chronic lymphocytic and can also treat solid tumors such as breast cancer and sarcoma. For instance, in 2021, according to the American Cancer Society, a voluntary health organization, global cancer patients diagnosed is expected to reach 1.9 million in 2021. Due to population increase and age, the worldwide burden of cancer is predicted to reach 27.5 million new cases and 16.2 million cancer deaths by 2040. Therefore, the rising prevalence of cancer disease is anticipated to boost the chimeric antigen receptor T (CAR-T) cells market in the upcoming years.

Product innovation is a key trend gaining popularity in the chimeric antigen receptor T (CAR-T) cells market. Major market players operating in the chimeric antigen receptor T (CAR-T) cells market are concentrating their efforts on creating innovative technologies to develop novel CAR-T cell-based treatments. For instance, in December 2021, Novartis AG, a Switzerland-based pharmaceutical company specializing in the development and manufacturing of drugs launched the T-Charge CAR-T platform. This technology-enabled platform enables the self to renew and maturation CAR-T cells offering a greater proliferative environment for cells.

In November 2021, Laurus Labs, an India-based pharmaceutical and biotechnology company acquired a substantial minority stake (26.62%) in Immunoadoptive Cell Therapy (ImmunoACT) for $5.56 million (INR 0.46 billion). With this acquisition, Laurus Labs will strengthen its biologics business and gains access to an emerging field of research. Immunoadoptive Cell Therapy is an India-based CAR-T cell-therapy company.

The countries covered in the chimeric antigen receptor T (CAR-T) cells market report are: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The chimeric antigen receptor T (CAR-T) market research report is one of a series of new reports from The Business Research Company that provides chimeric antigen receptor T (CAR-T) market statistics, including chimeric antigen receptor T (CAR-T) industry global market size, regional shares, competitors with a chimeric antigen receptor T (CAR-T) market share, detailed chimeric antigen receptor T (CAR-T) market segments, market trends and opportunities, and any further data you may need to thrive in the chimeric antigen receptor T (CAR-T) industry. This chimeric antigen receptor T (CAR-T) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Product Code: r5523

1. Executive Summary

2. Chimeric Antigen Receptor T (CAR-T) Cells Market Characteristics

3. Chimeric Antigen Receptor T (CAR-T) Cells Market Trends And Strategies

4. Chimeric Antigen Receptor T (CAR-T) Cells Market - Macro Economic Scenario

4.1. COVID-19 Impact On Chimeric Antigen Receptor T (CAR-T) Cells Market
4.2. Ukraine-Russia War Impact On Chimeric Antigen Receptor T (CAR-T) Cells Market
4.3. Impact Of High Inflation On Chimeric Antigen Receptor T (CAR-T) Cells Market

5. Chimeric Antigen Receptor T (CAR-T) Cells Market Size And Growth

5.1. Global Chimeric Antigen Receptor T (CAR-T) Cells Historic Market, 2017-2022, $ Billion
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints On The Market
5.2. Global Chimeric Antigen Receptor T (CAR-T) Cells Forecast Market, 2022-2027F, 2032F, $ Billion
- 5.2.1. Drivers Of The Market
- 5.2.2. Restraints On the Market

6. Chimeric Antigen Receptor T (CAR-T) Cells Market Segmentation

6.1. Global Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By Target Antigen, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
CD19
CD22
Other Antigens
6.2. Global Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Acute Lymphoblastic Leukaemia
Diffuse Large B-Cell Lymphoma
Other Applications
6.3. Global Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Hospitals
Cancer Research Centres
Clinics

7. Chimeric Antigen Receptor T (CAR-T) Cells Market Regional And Country Analysis

7.1. Global Chimeric Antigen Receptor T (CAR-T) Cells Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
7.2. Global Chimeric Antigen Receptor T (CAR-T) Cells Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

8. Asia-Pacific Chimeric Antigen Receptor T (CAR-T) Cells Market

8.1. Asia-Pacific Chimeric Antigen Receptor T (CAR-T) Cells Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By Target Antigen, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
8.3. Asia-Pacific Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

9. China Chimeric Antigen Receptor T (CAR-T) Cells Market

9.1. China Chimeric Antigen Receptor T (CAR-T) Cells Market Overview
9.2. China Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By Target Antigen, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
9.3. China Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

10. India Chimeric Antigen Receptor T (CAR-T) Cells Market

10.1. India Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By Target Antigen, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
10.2. India Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

11. Japan Chimeric Antigen Receptor T (CAR-T) Cells Market

11.1. Japan Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By Target Antigen, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
11.2. Japan Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

12. Australia Chimeric Antigen Receptor T (CAR-T) Cells Market

12.1. Australia Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By Target Antigen, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
12.2. Australia Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

13. Indonesia Chimeric Antigen Receptor T (CAR-T) Cells Market

13.1. Indonesia Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By Target Antigen, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
13.2. Indonesia Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

14. South Korea Chimeric Antigen Receptor T (CAR-T) Cells Market

14.1. South Korea Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By Target Antigen, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
14.2. South Korea Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

15. Western Europe Chimeric Antigen Receptor T (CAR-T) Cells Market

15.1. Western Europe Chimeric Antigen Receptor T (CAR-T) Cells Market Overview
15.2. Western Europe Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By Target Antigen, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
15.3. Western Europe Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

16. UK Chimeric Antigen Receptor T (CAR-T) Cells Market

16.1. UK Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By Target Antigen, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
16.2. UK Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

17. Germany Chimeric Antigen Receptor T (CAR-T) Cells Market

17.1. Germany Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By Target Antigen, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
17.2. Germany Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

18. France Chimeric Antigen Receptor T (CAR-T) Cells Market

18.1. France Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By Target Antigen, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
18.2. France Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

19. Eastern Europe Chimeric Antigen Receptor T (CAR-T) Cells Market

19.1. Eastern Europe Chimeric Antigen Receptor T (CAR-T) Cells Market Overview
19.2. Eastern Europe Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By Target Antigen, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
19.3. Eastern Europe Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

20. Russia Chimeric Antigen Receptor T (CAR-T) Cells Market

20.1. Russia Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By Target Antigen, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
20.2. Russia Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

21. North America Chimeric Antigen Receptor T (CAR-T) Cells Market

21.1. North America Chimeric Antigen Receptor T (CAR-T) Cells Market Overview
21.2. North America Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By Target Antigen, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
21.3. North America Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

22. USA Chimeric Antigen Receptor T (CAR-T) Cells Market

22.1. USA Chimeric Antigen Receptor T (CAR-T) Cells Market Overview
22.2. USA Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By Target Antigen, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
22.3. USA Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

23. South America Chimeric Antigen Receptor T (CAR-T) Cells Market

23.1. South America Chimeric Antigen Receptor T (CAR-T) Cells Market Overview
23.2. South America Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By Target Antigen, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
23.3. South America Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

24. Brazil Chimeric Antigen Receptor T (CAR-T) Cells Market

24.1. Brazil Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By Target Antigen, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
24.2. Brazil Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

25. Middle East Chimeric Antigen Receptor T (CAR-T) Cells Market

25.1. Middle East Chimeric Antigen Receptor T (CAR-T) Cells Market Overview
25.2. Middle East Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By Target Antigen, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
25.3. Middle East Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

26. Africa Chimeric Antigen Receptor T (CAR-T) Cells Market

26.1. Africa Chimeric Antigen Receptor T (CAR-T) Cells Market Overview
26.2. Africa Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By Target Antigen, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
26.3. Africa Chimeric Antigen Receptor T (CAR-T) Cells Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

27. Chimeric Antigen Receptor T (CAR-T) Cells Market Competitive Landscape And Company Profiles

27.1. Chimeric Antigen Receptor T (CAR-T) Cells Market Competitive Landscape
27.2. Chimeric Antigen Receptor T (CAR-T) Cells Market Company Profiles
- 27.2.1. Novartis International AG
  - 27.2.1.1. Overview
  - 27.2.1.2. Products and Services
  - 27.2.1.3. Strategy
  - 27.2.1.4. Financial Performance
- 27.2.2. Pfizer Inc
  - 27.2.2.1. Overview
  - 27.2.2.2. Products and Services
  - 27.2.2.3. Strategy
  - 27.2.2.4. Financial Performance
- 27.2.3. Gilead Sciences Inc
  - 27.2.3.1. Overview
  - 27.2.3.2. Products and Services
  - 27.2.3.3. Strategy
  - 27.2.3.4. Financial Performance
- 27.2.4. Autolus Therapeutics Plc
  - 27.2.4.1. Overview
  - 27.2.4.2. Products and Services
  - 27.2.4.3. Strategy
  - 27.2.4.4. Financial Performance
- 27.2.5. CARsgen Therapeutics Company Limited
  - 27.2.5.1. Overview
  - 27.2.5.2. Products and Services
  - 27.2.5.3. Strategy
  - 27.2.5.4. Financial Performance

28. Key Mergers And Acquisitions In The Chimeric Antigen Receptor T (CAR-T) Cells Market

29. Chimeric Antigen Receptor T (CAR-T) Cells Market Future Outlook and Potential Analysis

30. Appendix

30.1. Abbreviations
30.2. Currencies
30.3. Historic And Forecast Inflation Rates
30.4. Research Inquiries
30.5. The Business Research Company
30.6. Copyright And Disclaimer